1. Search Result
Search Result
Results for "

G-1

" in MedChemExpress (MCE) Product Catalog:

433

Inhibitors & Agonists

14

Biochemical Assay Reagents

7

Peptides

46

Inhibitory Antibodies

62

Natural
Products

57

Recombinant Proteins

15

Isotope-Labeled Compounds

13

Antibodies

2

Click Chemistry

10

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-107216
    G-1
    25+ Cited Publications

    Estrogen Receptor/ERR Cancer
    G-1 is a nonsteroidal, high-affinity and selective agonist of GPR30 with a Ki of 11 nM.
    G-1
  • HY-160580

    Liposome Others
    G1-OC2-K3-E10 is an ionizable lipid, and can be used for delivery of mRNA in lipid nanoparticles (LNPs) [1].
    G1-OC2-K3-E10
  • HY-137449

    G1T48

    Estrogen Receptor/ERR CDK Cancer
    Rintodestrant (G1T48) is an orally active, non-steroidal and selective estrogen receptor degrader. Rintodestrant (G1T48) is also a CDK4/6 inhibitor [1].
    Rintodestrant
  • HY-112272
    Lerociclib
    1 Publications Verification

    G1T38

    CDK Cancer
    Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 1 nM, 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively.
    Lerociclib
  • HY-112272A
    Lerociclib dihydrochloride
    1 Publications Verification

    G1T38 dihydrochloride

    CDK Cancer
    Lerociclib dihydrochloride (G1T38 dihydrochloride) is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 1 nM and 2 nM for CDK4/CyclinD1 and CDK6/CyclinD3, respectively.
    Lerociclib dihydrochloride
  • HY-101467A
    Trilaciclib hydrochloride
    1 Publications Verification

    G1T28 hydrochloride

    CDK Cancer
    Trilaciclib (G1T28) hydrochloride is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. Trilaciclib hydrochloride can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib hydrochloride attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy [1].
    Trilaciclib hydrochloride
  • HY-101467
    Trilaciclib
    1 Publications Verification

    G1T28

    CDK Cancer
    Trilaciclib (G1T28) is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. . Trilaciclib can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy [1].
    Trilaciclib
  • HY-158861

    G1-nPr-C14E

    Liposome Others
    C3-K2-E14 is a multi-ionizable amino-lipid featuring a central tertiary amine with two identical branches and an n-propyl group. Each branch features a propanamide linking to a branched amine, each with two C14 arms and a hydroxyl. Ionizable lipids such as this may be applied in the development of lipid nanoparticles for drug discovery.
    C3-K2-E14
  • HY-158455

    FA2[3]BG1 & FA2[6]BG1 glycan N-linked oligosaccharide, 2-AA labelled; G1F with bisecting GlcNAc, 2-AA labelled

    Biochemical Assay Reagents Others
    FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AA labelled (FA2[3]BG1 & FA2[6]BG1 glycan N-linked oligosaccharide, 2-AA labelled; G1F with bisecting GlcNAc, 2-AA labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AA labelled
  • HY-158456

    FA2[3]BG1 & FA2[6]BG1 glycan N-linked oligosaccharide, 2-AB labelled; G1F with bisecting GlcNAc, 2-AB labelled

    Biochemical Assay Reagents Others
    FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AB labelled (FA2[3]BG1 & FA2[6]BG1 glycan N-linked oligosaccharide, 2-AB labelled; G1F with bisecting GlcNAc, 2-AB labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]BG1 & FA2[6]BG1 glycan (G1B), 2-AB labelled
  • HY-129848

    Others Others
    Cucumarioside G1 is a triterpene glycoside and can be isolated from Cucumaria fraudatrix [1].
    Cucumarioside G1
  • HY-112197
    PKG drug G1
    2 Publications Verification

    PKG Cardiovascular Disease
    PKG agent G1 targets C42 of PKG Iα. PKG agent G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
    PKG drug G1
  • HY-W127501

    Biochemical Assay Reagents Others
    Prostaglandin G1 is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Prostaglandin G1
  • HY-N3521

    Deapi-platycoside E

    Others Others
    Platycoside G1, a natural product found in Platycodon grandiflorum, is a triterpenoid saponin. Platycoside G1 has potent antioxidant activities [1].
    Platycoside G1
  • HY-W582827

    Biochemical Assay Reagents Endogenous Metabolite
    RuPhos Pd G1 methyl t-butyl ether adduct (MTBE) is a highly efficient catalyst with excellent cross-coupling activity. RuPhos Pd G1 methyl t-butyl ether adduct (MTBE) is widely used in organic synthesis and can be used to promote various reactions to build complex molecular structures. RuPhos Pd G1 methyl t-butyl ether adduct (MTBE) has good adaptability to temperature and reaction conditions, which enables it to exhibit excellent catalytic performance in different reaction systems.
    RuPhos Pd G1 methyl t-butyl ether adduct (MTBE)
  • HY-158523

    A2[3]G1 & A2[6]G1 N-linked oligosaccharide

    Biochemical Assay Reagents Others
    A2[3]G1 & A2[6]G1 glycan (G1) (A2[3]G1 & A2[6]G1 N-linked oligosaccharide) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    A2[3]G1 & A2[6]G1 glycan (G1)
  • HY-158520

    A2[3]G1 & A2[6]G1 N-linked oligosaccharide, 2-AA labelled

    Biochemical Assay Reagents Others
    A2[3]G1 & A2[6]G1 glycan (G1), 2-AA labelled (A2[3]G1 & A2[6]G1 N-linked oligosaccharide, 2-AA labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    A2[3]G1 & A2[6]G1 glycan (G1), 2-AA labelled
  • HY-158522

    A2[3]G1 & A2[6]G1 N-linked oligosaccharide, 2-AB labelled

    Biochemical Assay Reagents Others
    A2[3]G1 & A2[6]G1 glycan (G1), 2-AB labeled Lewis sugar. SLeX is a ligand for the cell adhesion molecule E-selectin (E-selectin), which is specifically expressed at sites of inflammatory lesions. Designing SLeX-polysaccharide conjugates to deliver drugs to inflammatory lesions [1].
    A2[3]G1 & A2[6]G1 glycan (G1), 2-AB labelled
  • HY-158473

    FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide

    Biochemical Assay Reagents Others
    FA2[3]G1 & FA2[6]G1 glycan (G1F) (FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]G1 & FA2[6]G1 glycan (G1F)
  • HY-158480

    FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, procainamide labelled

    Biochemical Assay Reagents Others
    FA2[3]G1 & FA2[6]G1 glycan (G1F), procainamide labelled (FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, procainamide labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]G1 & FA2[6]G1 glycan (G1F), procainamide labelled
  • HY-158479

    FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, APTS labelled

    Biochemical Assay Reagents Others
    FA2[3]G1 & FA2[6]G1 glycan (G1F), APTS labelled (FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, APTS labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]G1 & FA2[6]G1 glycan (G1F), APTS labelled
  • HY-158481

    FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, 2-AA labelled

    Biochemical Assay Reagents Others
    FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AA labelled (FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, 2-AA labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AA labelled
  • HY-158478

    FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, 2-AB labelled

    Biochemical Assay Reagents Others
    FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AB labelled (FA2[3]G1 & FA2[6]G1 N-linked oligosaccharide, 2-AB labelled) is a N-polysaccharide protein and a multifunctional fluorescent linker. The resulting conjugates exhibit high sensitivity and specificity by mimicking the antennal elements of N-glycans [1].
    FA2[3]G1 & FA2[6]G1 glycan (G1F), 2-AB labelled
  • HY-169047

    PAMAM G1.5 carboxylate sodium

    SARS-CoV Infection
    PAMAM dendrimer G1.5 carboxylate (PAMAM G1.5 carboxylate) sodium is a polyanionic dendrimers comprising the terminal groups sodium carboxylate. PAMAM dendrimer G1.5 carboxylate shows antiviral activity with the MERS‐CoV plaque inhibition assay, with the inhibition rate of 40.5% [1].
    PAMAM dendrimer G1.5 carboxylate sodium
  • HY-158457

    N/A

    Biochemical Assay Reagents Others
    A2[3]G1 N-glycan (N/A) is a Lewis sugar. SLeX is a ligand for the cell adhesion molecule E-selectin, which is specifically expressed at sites of inflammatory lesions. Designing SLeX-polysaccharide conjugates to deliver drugs to inflammatory lesions [1].
    A2[3]G1 N-glycan
  • HY-169474

    PAMAM G1.0

    Biochemical Assay Reagents Cancer
    Starburst 1st Generation (PAMAM G1.0) is a Polyamidoamine (HY-164657; PAMAM) dendrimer with amine termini that has been used as a drug delivery system in vitro. Starburst 1st Generation conjugated to di-n-dodecylamine and encapsulating 5-Fluorouracil (HY-90006) increase the solubility of 5-Fluorouracil and are cytotoxic to AGS gastric adenocarcinoma cells [1].
    Starburst 1st generation (13.93% in water)
  • HY-115932

    Aurora Kinase Apoptosis Cancer
    Aurora kinase-IN-1 (Compound 9) is a potent inhibitor of aurora kinase. Aurora kinase-IN-1 upregulates the expression of G1 cell cycle inhibitory proteins including p21 and p27, and G1 progressive cyclin D1, and downregulates G1-to-S progressive cyclins, resulting in cell cycle arrest at the G1/S boundary. Aurora kinase-IN-1 also induces apoptosis. Aurora kinase-IN-1 is a lead compound for chemotherapeutic agents [1].
    Aurora kinase-IN-1
  • HY-158495

    A2 N-linked oligosaccharide, 2-AA labelled

    Biochemical Assay Reagents Others
    A2[3]G1 & A2[6]G1 glycan (G1), 2-AB labeled Lewis sugar. SLeX is a ligand for the cell adhesion molecule E-selectin (E-selectin), which is specifically expressed at sites of inflammatory lesions. Designing SLeX-polysaccharide conjugates to deliver drugs to inflammatory lesions [1].
    A2 glycan (G0), 2-AA labelled
  • HY-P990716

    PD-1/PD-L1 Inflammation/Immunology
    Sabestomig is an anti-PDCD1/HAVCR2 Ig(G1G1-λ2) monoclonal antibody [1].
    Sabestomig
  • HY-P991003

    TNF Receptor Inflammation/Immunology
    HY-P991003 is an TNFRSF17/KLRK1-targeting (G1_L-κ)_(G1-scFvkh_L-κ) type bispecific antibody [1].
    Ingitamig
  • HY-P990947

    EGFR Inflammation/Immunology
    HY-P990947 is an EGFR/MET-targeting Ig(G1 -κ_G1 -λ2) type human antibody [1].
    Tilatamig
  • HY-P990020

    c-Kit Others
    Eglatoprutug is an humanized immunoglobulin G1-kappa, anti-c-Kit monoclonal antibody [1].
    Eglatoprutug
  • HY-P990953

    Gen1047

    CD3 Inflammation/Immunology
    HY-P990953 is an CD3E/VTCN1-targeting Ig(G1 -κ_G1 -λ2) type chimeric human antibody [1].
    Zubotamig
  • HY-P990047

    AMG133 antibody

    GLP Receptor Metabolic Disease
    Maridebart is a human immunoglobulin G1-kappa, anti-GIPR (gastric inhibitory polypeptide receptor) monoclonal antibody [1].
    Maridebart
  • HY-P990048

    CTLA-4 Cancer
    Muzastotug is a humanized immunoglobulin G1-kappa, anti-CTLA4 monoclonal antibody. Muzastotug is an immunostimulant and antineoplastic [1].
    Muzastotug
  • HY-155552

    Molecular Glues Apoptosis Cancer
    GSPT1 degrader-1 (compound 9q) is a potent degrader of G1 to S phase transition 1 (GSPT1) via ubiquitin-proteasome system, serves as one of Molecular Glues. GSPT1 degrader-1 also induces cell G0/G1 phase arrest and apoptosis [1].
    GSPT1 degrader-1
  • HY-P991033

    VEGFR Inflammation/Immunology
    HY-P991033 is an VEGFA/DLL4-targeting G1-scFvlh_L-κ type bispecific antibody [1].
    Tovecimig
  • HY-147407

    EGFR Cancer
    Imbotolimod, immunoglobulin G1-kappa, is a humanized monoclonal antibody with anti-ERBB2 and antineoplastic activity. Imbotolimod is a derivative of telratolimod [1].
    Imbotolimod
  • HY-P990080

    CTLA-4 Cancer
    Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic [1].
    Sovipostobart
  • HY-152245

    Epigenetic Reader Domain Cancer
    Physachenolide C is a potent and selective BET inhibitor that induces apoptosis and arrests the cell cycle in the G0-G1 phase, with antitumor activity [1].
    Physachenolide C
  • HY-124261

    Apoptosis Cancer
    Sampangine is an alkaloid that induces apoptosis by inducing cell cycle arrest in the G0/G1 phase. Sampangine can inhibit the biosynthesis of heme [1] .
    Sampangine
  • HY-13650
    Indisulam
    10+ Cited Publications

    E 7070

    Molecular Glues Carbonic Anhydrase Cancer
    Indisulam (E 7070) is a carbonic anhydrase inhibitor with anticancer activity. Indisulam (E 7070) is a sulfonamide agent that targets the G1 phase of the cell cycle. Indisulam (E 7070) causes a blockade in the G1/S transition through inhibition of the activation of both CDK2 and cyclin E. Indisulam (E 7070) targets splicing by inducing RBM39 degradation via recruitment to DCAF15 [1] .
    Indisulam
  • HY-P990932

    BI 764532; OBT 620

    CD3 Inflammation/Immunology
    HY-P990932 is an CD3E/HEK-targeting L-κ-G1-h-CH2-CH3_L-λ-G1-h-CH2-CH3 type human antibodychimeric antibody [1].
    Obrixtamig
  • HY-P990079

    CD28 Inflammation/Immunology
    Renvistobart is an immunoglobulin G1-κ, anti-[Homo sapiens TIGIT (T cell immunoreceptor with Ig domain and ITIM, VSIG9, VSTM3)] Homo sapiens monoclonal antibody [1].
    Renvistobart
  • HY-N1150
    Thymidine
    10+ Cited Publications

    DThyd; NSC 21548

    DNA/RNA Synthesis Endogenous Metabolite Orthopoxvirus Cancer
    Thymidine, a specific precursor of deoxyribonucleic acid, is used as a cell synchronizing agent. Thymidine is a DNA synthesis inhibitor that can arrest cell at G1/S boundary, prior to DNA replication [1] .
    Thymidine
  • HY-N12603

    Apoptosis Cancer
    Typhatifolin B (Compd 2), an anti-cancer agent, could remarkably induce cell apoptosis and G0/G1 cycle arrest, as well as block cell migration and invasion [1].
    Typhatifolin B
  • HY-169932

    Apolipoprotein Infection
    APOL1-IN-2 (Compound 467) is the inhibitor for Apolipoprotein 1 (APOL1). APOL1-IN-2 reduces the APOL1 G2/G1 induced cell death in HEK293 with EC50 of 4.74 nM and 14.3 nM. APOL1-IN-2 reduces the APOL1 G2/G1/G0 induced death of trypanosomes with EC50 of 2.24, 6.03 and 3.72 nM, respectively [1].
    APOL1-IN-2
  • HY-152135

    Apoptosis Cancer
    TJ08, a 1,2,5-trisubstituted benzimidazole derivative, efficiently induces G1/S phase arrest and promotes apoptosis in various cancer cells. TJ08 is an anticancer agent [1].
    TJ08
  • HY-P99367

    CD3 Inflammation/Immunology Cancer
    Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur [1].
    Ifinatamab
  • HY-13768C

    SKF 104864A hydrochloride hydrate; NSC 609669 hydrochloride hydrate

    Topoisomerase Apoptosis Autophagy Cancer
    Topotecan hydrochloride hydrate is an orally active and potent Topoisomerase I inhibitor. Topotecan hydrochloride hydrate induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan hydrochloride hydrate shows anticancer activity [1].
    Topotecan hydrochloride hydrate

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: